Locana, Inc., an RNA-targeting gene therapy company, has appointed James Burns, Ph.D., as chief executive officer. The company is expanding its leadership team as part of a planned transition of the company’s director and recent chief executive officer, Jeffrey M. Ostrove, Ph.D., who will continue to serve as director.  Mr. Burns is an accomplished company builder and biopharmaceutical product developer. He joins Kathie Bishop, Ph.D., Locana’s chief scientific officer, in carrying...